Improved clinical and simplified disease activity index (CDAI, SDAI) scores with rituximab in patients with rheumatoid arthritis (RA) and an inadequate response to TNF inhibitors

被引：0
|
作者：
Smolen, Josef [1 ]
Cividino, Alfred [2 ]
Kavanugh, Arthur [3 ]
Tony, Hans Peter [4 ]
Greenwald, Maria
De Vita, Salvatore [5 ]
Brasington, Richard [6 ]
Aletaha, Daniel [7 ]
White, Anne Marie [8 ]
Hessey, Eva [8 ]
机构：
[1] Med Univ Vienna, Vienna, Austria
[2] McMaster Univ, Hamilton, ON L8S 4L8, Canada
[3] UCSD, La Jolla, CA USA
[4] Univ Klinikum Wurzburg, Wurzburg, Germany
[5] Univ Udine, I-33100 Udine, Italy
[6] Washington Sch Med, St Louis, MO USA
[7] Med Univ Vienna, Vienna, Austria
[8] Roche Prod Ltd, Welwyn Garden City AL7 3AY, Herts, England
来源：
JOURNAL OF RHEUMATOLOGY | 2008年 / 35卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1191 / 1191
页数：1
相关论文
共 50 条
  • [31] ASSESSMENT OF DISEASE ACTIVITY IN RHEUMATOID ARTHRITIS BY ROUTINE ASSESSMENT OF RHEUMATOID ARTHRITIS DISEASE ACTIVITY INDEX (RADAI) AND ITS RELATION WITH DISEASE ACTIVITY SCORE 28 (DAS28), CLINICAL DISEASE ACTIVITY INDEX (CDAI) AND SIMPLIFIED DISEASE ACTI
    Kaygisiz, F.
    Borman, P.
    Tuncay, F.
    Okumus, M.
    Erdem, R.
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 : 838 - 838
  • [32] Rheumatoid factor level unexpectedly increased by the tocilizumab in rheumatoid arthritis patients with good clinical response and previous inadequate response to TNF inhibitors
    Kaliterna, D. Martinovic
    Radic, M.
    Perkovic, D.
    Krstulovic, D. Marasovic
    Marinovic, I.
    Boric, K.
    Aljinovic, J.
    WIENER KLINISCHE WOCHENSCHRIFT, 2014, 126
  • [33] Repeat treatment with rituximab improves physical function and quality of life in patients with rheumatoid arthritis and an inadequate response to TNF inhibitors.
    Tak, Paul P.
    Mease, Philip J.
    Bombardieri, Stefano
    Lue, Cummins
    Isaacs, John D.
    Schechtman, Jc
    Gray, Diep
    Cravets, Matthew W.
    Safa-Leathers, Simon
    ARTHRITIS AND RHEUMATISM, 2006, 54 (09): : S403 - S403
  • [34] Mortality in rheumatoid arthritis: the impact of disease activity, treatment with glucocorticoids, TNFα inhibitors and rituximab
    Listing, Joachim
    Kekow, Joern
    Manger, Bernhard
    Burmester, Gerd-Ruediger
    Pattloch, Dagmar
    Zink, Angela
    Strangfeld, Anja
    ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 (02) : 415 - 421
  • [35] A simplified disease activity index for rheumatoid arthritis for use in clinical practice
    Smolen, JS
    Breedveld, FC
    Schiff, MH
    Kalden, JR
    Emery, P
    Eberl, G
    van Riel, PL
    Tugwell, P
    RHEUMATOLOGY, 2003, 42 (02) : 244 - 257
  • [36] Definition of Treatment Response in Rheumatoid Arthritis Based on the Simplified and the Clinical Disease Activity Index.
    Aletaha, Daniel
    Martinez-Avila, Jose
    Kvien, Tore K.
    Smolen, Josef S.
    ARTHRITIS AND RHEUMATISM, 2011, 63 (10): : S869 - S870
  • [37] EARLY CLINICAL IMPROVEMENTS (WEEK 4) PREDICT SUBSEQUENT CLINICAL RESPONSE WITH IXEKIZUMAB IN RHEUMATOID ARTHRITIS PATIENTS WITH INADEQUATE RESPONSE TO TNF INHIBITORS
    Xie, L.
    Genovese, M. C.
    Zhu, B.
    Edson-Heredia, E.
    Banerjee, S.
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 : 628 - 628
  • [38] Test–retest reliability of the Disease Activity Score 28 CRP (DAS28-CRP), the Simplified Disease Activity Index (SDAI) and the Clinical Disease Activity Index (CDAI) in rheumatoid arthritis when based on patient self-assessment of tender and swollen joints
    Cecilie Heegaard
    Lene Dreyer
    Charlotte Egsmose
    Ole Rintek Madsen
    Clinical Rheumatology, 2013, 32 : 1493 - 1500
  • [39] Repeated treatment courses of rituximab produce sustained efficacy in patients with rheumatoid arthritis and an inadequate response or intolerance to one or more TNF inhibitors
    Emery, Paul
    Keystone, Edward
    Fleischmann, Roy
    Chubick, Andrew
    Dougados, Maxime
    Baldassare, Andrew
    Bathon, Joan
    Hessey, Eva
    Hagerty, David
    Cooper, Simon
    RHEUMATOLOGY, 2008, 47 : II45 - II45
  • [40] Oral glucocorticoids have no impact on the efficacy or safety profile of rituximab in rheumatoid arthritis patients with inadequate response to TNF inhibitors (REFLEX study)
    Burmester, G. R.
    Ruderman, E. M.
    Durez, P.
    Loveless, J.
    Kvien, T. K.
    Jackson, C.
    Burke, L.
    Cravets, M.
    White, A. M.
    ANNALS OF THE RHEUMATIC DISEASES, 2006, 65 : 180 - 180
12345